This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

KCI’s LifeCell™ Business Names Michael G. Franz, M.D. Vice President Of Global Clinical & Medical Affairs

Kinetic Concepts, Inc. (NYSE: KCI), announced today that Michael G. Franz, M.D., FACS, has been named vice president of Global Clinical & Medical Affairs for LifeCell™, a business unit of KCI that specializes in regenerative medicine.

As VP of Global Clinical & Medical Affairs for LifeCell™, Franz will be responsible for establishing overall clinical and medical strategies, completing clinical studies and providing input into new product activities. He will also work closely with the commercial and research & development teams company-wide.

Franz most recently served as chief, Division of Minimally Invasive Surgery, University of Michigan Department of Surgery, Section of General Surgery. He has more than 20 years of surgical medical experience and is a globally recognized leader and published researcher in the field of wound healing, abdominal wall pathophysiology, tissue engineering and surgical innovation. He previously served on KCI’s Scientific Advisory Board, a committee of leading clinical experts that provides medical guidance to the company.

“Mike shares KCI’s deep passion for regenerative medicine, the advancement of surgical techniques and maximizing patient outcomes,” said Lisa Colleran, president, LifeCell™. “As we continue to grow and launch more products in more places, his expertise in clinical evidence and patient efficacy, and his research in wound healing and tissue engineering around the world, will greatly contribute to our continued success and innovation.”

"Mike is an internationally recognized expert and authority in the field of biologics and biologic materials," said Ron Silverman, M.D., chief medical officer, KCI. "His scientific and critical thinking will further KCI's commitment to improving the lives of patients."

About KCI

Kinetic Concepts, Inc. (NYSE:KCI) is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. Headquartered in San Antonio, Texas, KCI's success spans more than three decades and can be traced to a history deeply rooted in innovation and a passion for significantly improving the healing and the lives of patients around the world. The company employs approximately 7,100 people and markets its products in more than 20 countries. For more information about KCI and how its products are changing the practice of medicine, visit

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,693.38 -82.74 -0.47%
S&P 500 2,060.73 -7.16 -0.35%
NASDAQ 4,874.2190 -26.6660 -0.54%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs